Medium severity · published Apr 23, 2026
CVE-2026-41360
OpenClaw < 2026.4.2 - Approval Integrity Bypass in pnpm dlx Local Script Binding
6.7
CVSS
0.1%
EPSS
No
On KEV
Description
OpenClaw before 2026.4.2 contains an approval integrity vulnerability in pnpm dlx that fails to bind local script operands consistently with pnpm exec flows. Attackers can replace approved local scripts before execution without invalidating the approval plan, allowing execution of modified script contents.
CVSS vector
CVSS:3.1/AV:L/AC:H/PR:L/UI:R/S:U/C:H/I:H/A:H
Attack vector
Local
Complexity
High
Privileges
Low
User interaction
Required
Confidentiality
High
Integrity
High
Availability
High
Scope
Unchanged
Exploitation
Is it being used?
Exploit prediction (EPSS)0.1% · higher than 0% of CVEs
Exploited in the wildNo evidence yet
CISA KEVNot listed
Ransomware campaign useNot known
Affected products
Which versions
OP
OpenClaw · OpenClaw
before 2026.4.2 · source: vendor, NVD
References
NVD
https://nvd.nist.gov/vuln/detail/CVE-2026-41360
CVE.org
https://www.cve.org/CVERecord?id=CVE-2026-41360
Patch
https://github.com/openclaw/openclaw/commit/176c059b05357df1bc09d4328a2380670859eeff
Vendor Advisory
https://github.com/openclaw/openclaw/security/advisories/GHSA-w6wx-jq6j-6mcj
Third Party Advisory
https://www.vulncheck.com/advisories/openclaw-approval-integrity-bypass-in-pnpm-dlx-local-script-binding
More from OpenClaw
9.9
CVE-2026-41329
OpenClaw < 2026.3.31 - Sandbox Bypass via Heartbeat Context Inheritance and senderIsOwner Escalation
9.9
CVE-2026-33579
OpenClaw < 2026.3.28 - Privilege Escalation via Missing Caller Scope Validation in Device Pair Approval
9.9
CVE-2026-32922
OpenClaw < 2026.3.11 - Privilege Escalation via Unvalidated Scope in device.token.rotate
9.9
CVE-2026-32048
OpenClaw < 2026.3.1 - Sandbox Escape via Cross-Agent sessions_spawn
9.9
CVE-2026-22172
OpenClaw < 2026.3.12 - Scope Elevation in WebSocket Shared-Auth Connections